Fu Yu Corporation (F13) Q3 2023 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2023 TU earnings summary
29 Oct, 2026Executive summary
3Q23 revenue fell 7.5% YoY to S$33.1 million; 9M23 revenue declined 34.0% to S$104.3 million, with softer manufacturing and supply chain services activity.
9M23 net loss was S$5.8 million, versus net profit of S$15.6 million in 9M22.
Financial highlights
9M23 gross profit contracted to S$9.5 million from S$29.5 million in 9M22, in line with lower revenue.
Manufacturing gross profit fell to S$9.2 million from S$27.1 million; lower sales caused fixed-cost under-absorption.
Outlook and guidance
Operating conditions are expected to remain challenging amid elevated interest rates, macroeconomic slowdown, inflation and higher cost pressures.
Priorities include strengthening the business foundation, maintaining balance-sheet resilience and pursuing growth opportunities while monitoring conditions.
Latest events from Fu Yu Corporation
- Revenue fell 58% as weaker demand drove a quarterly loss; transformation targets biomedical growth.F13
Q1 2023 TU - Weaker demand drove a 1H23 loss as investment targeted higher-value growth.F13
H1 2023 - Smart Factory and biomedical expansion anchor the shift to higher-precision growth.F13
Corporate presentation - FY2023 loss amid weaker demand; recovery and transformation support FY2024 improvement.F13
H2 2023 - Revenue more than doubled, but manufacturing weakness limited net profit to S$5,200.F13
Q1 2024 TU - Revenue rose 78.0%, returning 1H2024 to profit as supply chain services led growth.F13
H1 2024 - 9M2024 revenue surged 55.2% as operating results returned to profit.F13
Q3 2024 TU - Revenue rose 10.4%, but closure and forex costs drove a S$9.805m continuing-operations loss.F13
H1 2025 - Core manufacturing grew, but one-off costs, FX losses and audit qualifications cloud recovery.F13
H2 2025